Syndax Pharmaceuticals Inc (SNDX)

CIK 1395937 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Syndax Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Aug 7, 2026SCHEDULE 13G0000093751-26-000542
Aug 4, 20268-K0001193125-26-332736
Aug 4, 202610-Q0001193125-26-332750
Jul 14, 20268-K0001193125-26-302608
Jul 9, 202640001193125-26-299803
Jul 8, 20261440001950047-26-006967
Jun 12, 202640001193125-26-269694
Jun 12, 20261440001959173-26-004618
Jun 11, 20261440001959173-26-004566
Jun 10, 20268-K0001193125-26-266027
Jun 10, 20268-K0001193125-26-265852
Jun 4, 20268-K0001193125-26-256458
Jun 4, 2026DEFA14A0001193125-26-256557
Jun 2, 202640001193125-26-253601
Jun 2, 202640001193125-26-253603
Jun 1, 20261440001959173-26-004216
Jun 1, 20261440001959173-26-004218
May 15, 2026SCHEDULE 13G/A0000919574-26-003472
Apr 30, 202610-Q0001193125-26-197154
Apr 30, 2026SCHEDULE 13G0002100119-26-001081
Apr 30, 2026DEF 14A0001193125-26-197859
Apr 30, 20268-K0001193125-26-197124
Apr 30, 2026ARS0001193125-26-197892
Apr 30, 2026DEFA14A0001193125-26-197877
Mar 27, 2026SCHEDULE 13G/A0000102909-26-002306